Total Payments
$426.11
2024 Payments
$36.80
Companies
13
Transactions
21
Medicare Patients
2,605
Medicare Billing
$489,755
Payment Breakdown by Category
Food & Beverage$398.14 (93.4%)
Education$27.97 (6.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $398.14 | 15 | 93.4% |
| Education | $27.97 | 6 | 6.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Aurinia Pharma U.S., Inc. | $122.14 | 1 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $76.13 | 4 | $0 (2017) |
| Outset Medical Inc | $47.46 | 1 | $0 (2018) |
| Fresenius USA Marketing, Inc. | $30.27 | 1 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $24.48 | 2 | $0 (2018) |
| Vifor Pharma, Inc. | $23.60 | 1 | $0 (2023) |
| Relypsa, Inc. | $18.98 | 1 | $0 (2018) |
| Lundbeck LLC | $16.26 | 1 | $0 (2017) |
| AMAG Pharmaceuticals, Inc. | $15.28 | 1 | $0 (2019) |
| Keryx Biopharmaceuticals, Inc. | $14.30 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $36.80 | 4 | Fresenius USA Marketing, Inc. ($30.27) |
| 2023 | $29.76 | 3 | Vifor Pharma, Inc. ($23.60) |
| 2021 | $122.14 | 1 | Aurinia Pharma U.S., Inc. ($122.14) |
| 2019 | $28.65 | 2 | AMAG Pharmaceuticals, Inc. ($15.28) |
| 2018 | $78.85 | 3 | Outset Medical Inc ($47.46) |
| 2017 | $129.91 | 8 | SANOFI-AVENTIS U.S. LLC ($76.13) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 09/25/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 04/11/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $30.27 | General |
| Category: Phosphate binder for ESRD | ||||||
| 01/29/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 12/15/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 10/18/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 08/23/2023 | Vifor Pharma, Inc. | Veltassa (Drug), Korsuva | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Hyperkalemia | ||||||
| 11/18/2021 | Aurinia Pharma U.S., Inc. | — | Food and Beverage | In-kind items and services | $122.14 | General |
| 11/14/2019 | AMAG Pharmaceuticals, Inc. | FERAHEME (Drug) | Education | In-kind items and services | $15.28 | General |
| Category: PARENTERAL IRON REPLACEMENT | ||||||
| 01/31/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: KRYSTEXXA | ||||||
| 05/09/2018 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Hyperkalemia | ||||||
| 04/19/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/08/2018 | Outset Medical Inc | — | Food and Beverage | Cash or cash equivalent | $47.46 | General |
| 11/09/2017 | Lundbeck LLC | NORTHERA (Drug) | Food and Beverage | Cash or cash equivalent | $16.26 | General |
| Category: NEUROLOGY | ||||||
| 09/21/2017 | Keryx Biopharmaceuticals, Inc. | Auryxia (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Nephrology | ||||||
| 09/14/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/25/2017 | SANOFI-AVENTIS U.S. LLC | RENVELA (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: RENAL | ||||||
| 08/14/2017 | SANOFI-AVENTIS U.S. LLC | RENVELA (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: RENAL | ||||||
| 06/05/2017 | SANOFI-AVENTIS U.S. LLC | RENVELA (Drug) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: RENAL | ||||||
| 05/15/2017 | SANOFI-AVENTIS U.S. LLC | RENVELA (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: RENAL | ||||||
| 03/23/2017 | Genentech USA, Inc. | Rituxan (Biological) | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: BioOncology/Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 492 | 911 | $193,223 | $93,655 |
| 2022 | 10 | 598 | 1,053 | $203,665 | $97,582 |
| 2021 | 12 | 741 | 1,399 | $278,010 | $150,104 |
| 2020 | 14 | 774 | 1,449 | $346,665 | $148,414 |
Total Patients
2,605
Total Services
4,812
Medicare Billing
$489,755
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 16 | 73 | $36,500 | $19,630 | 53.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 105 | 276 | $30,360 | $16,699 | 55.0% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 14 | 64 | $24,000 | $13,491 | 56.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 64 | 73 | $15,038 | $7,157 | 47.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 28 | 71 | $11,076 | $6,505 | 58.7% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 19 | 31 | $13,330 | $6,500 | 48.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 72 | 118 | $22,420 | $5,845 | 26.1% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 14 | 34 | $10,200 | $4,916 | 48.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 31 | 35 | $10,605 | $4,673 | 44.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $9,000 | $3,780 | 42.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 53 | $7,102 | $3,214 | 45.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 16 | 21 | $3,150 | $1,155 | 36.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 26 | 26 | $442.00 | $88.66 | 20.1% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 40 | 92 | $46,000 | $25,635 | 55.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 155 | 397 | $43,670 | $21,976 | 50.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 64 | 143 | $22,308 | $11,260 | 50.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 89 | 94 | $19,364 | $9,905 | 51.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 52 | 53 | $16,059 | $8,193 | 51.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 93 | 155 | $29,450 | $7,614 | 25.9% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 21 | 30 | $12,900 | $7,012 | 54.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 46 | $6,164 | $2,687 | 43.6% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 27 | 30 | $4,500 | $1,726 | 38.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $3,250 | $1,573 | 48.4% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 47 | 180 | $86,933 | $50,247 | 57.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 198 | 527 | $57,786 | $29,986 | 51.9% |
About Dr. Daniel Roncone, MD
Dr. Daniel Roncone, MD is a Internal Medicine healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1457333684.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Roncone, MD has received a total of $426.11 in payments from pharmaceutical and medical device companies, with $36.80 received in 2024. These payments were reported across 21 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($398.14).
As a Medicare-enrolled provider, Roncone has provided services to 2,605 Medicare beneficiaries, totaling 4,812 services with total Medicare billing of $489,755. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology
- Location Columbus, OH
- Active Since 11/15/2005
- Last Updated 08/06/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1457333684
Products in Payments
- RENVELA (Drug) $76.13
- Veltassa (Drug) $42.58
- Velphoro (Drug) $30.27
- ENTRESTO (Drug) $24.48
- NORTHERA (Drug) $16.26
- FERAHEME (Drug) $15.28
- Auryxia (Drug) $14.30
- KRYSTEXXA (Biological) $13.37
- Rituxan (Biological) $11.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Columbus
Anish Amin, M.d, M.D
Internal Medicine — Payments: $807,022
Internal Medicine $807,022
Dr. Alexa Meara, Md, MD
Internal Medicine — Payments: $377,655
Internal Medicine $377,655
Jayanta Mukherjee, Md, MD
Internal Medicine — Payments: $240,062
Internal Medicine $240,062
Dr. David Lo, M.d, M.D
Internal Medicine — Payments: $185,475
Internal Medicine $185,475
Narendranath Epperla, Md, MD
Internal Medicine — Payments: $184,240
Internal Medicine $184,240
Lucy Laperna, Do, DO
Internal Medicine — Payments: $133,632
Internal Medicine $133,632